These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31037416)

  • 1. Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal
    Nicastro N; Wegrzyk J; Preti MG; Fleury V; Van de Ville D; Garibotto V; Burkhard PR
    J Neurol; 2019 Jul; 266(7):1771-1781. PubMed ID: 31037416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrastriatal
    Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
    Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
    Nicastro N; Burkhard PR; Garibotto V
    J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 6. FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
    Hammesfahr S; Antke C; Mamlins E; Beu M; Wojtecki L; Ferrea S; Dinkelbach L; Moldovan AS; Schnitzler A; Müller HW; Südmeyer M
    Neurodegener Dis; 2016; 16(5-6):342-7. PubMed ID: 26978429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
    Pirker W; Djamshidian S; Asenbaum S; Gerschlager W; Tribl G; Hoffmann M; Brücke T
    Mov Disord; 2002 Jan; 17(1):45-53. PubMed ID: 11835438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H; Sung YH; Hwang KH
    Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
    Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
    J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of combining
    Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
    J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.
    Huppertz HJ; Möller L; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Respondek G; Stamelou M; Schnitzler A; Pinkhardt EH; Oertel WH; Knake S; Kassubek J; Höglinger GU
    Mov Disord; 2016 Oct; 31(10):1506-1517. PubMed ID: 27452874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of Parkinson disease by support vector machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age.
    Palumbo B; Fravolini ML; Buresta T; Pompili F; Forini N; Nigro P; Calabresi P; Tambasco N
    Medicine (Baltimore); 2014 Dec; 93(27):e228. PubMed ID: 25501084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
    Iwabuchi Y; Kameyama M; Matsusaka Y; Narimatsu H; Hashimoto M; Seki M; Ito D; Tabuchi H; Yamada Y; Jinzaki M
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1833-1841. PubMed ID: 33392714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.